Cleveland, OH
Defective and dangerous products Lawyer at Cleveland, OH
Practice Areas: Defective and Dangerous Products, Class Action, General Practice
October 19, 2010: The FDA approved Pradaxa (pdf) to prevent blood clot and stroke in people with atrial fibrillation. March 30, 2011: The FDA released a safety alert (pdf) stating that Pradaxa should o...
See Full GuideFebruary 19, 2003: Fresenius Medical Care submitted its application to the FDA for 510(k) clearance (pdf) of Naturalyte Granuflo Dry Acid Concentrate 10XX Series, 24XX Series, 30XXseries. "A 510(k) is ...
See Full GuideJuly 2, 2002: The FDA sent Medtronic an approval letter (pdf) in response to its premarket approval application for the InFUSE Bone Graft medical device. Per that letter and the Medical Devices Approva...
See Full GuideJanuary 4, 1991: The FDA approved Zofran (ondansetron) for chemotherapy-related nausea and vomiting (pdf). January 5, 1993: The New York Times reported that the FDA approved a pill form of Zofran (pdf)...
See Full GuideApril 15, 2011: Colorado issued a cease-and-desist order (pdf) to NECC for shipping drugs to the state without requiring individual prescriptions for each drug. September 21, 2012: The Tennessee Depar...
See Full GuideWhat is the drug involved in the NECC Fungal Meningitis Outbreak? It is called methylprednisone, and it is from one company, New England Compounding center, or NECC. It was shipped to 23 states, and th...
See Full GuideThe NECC fungal meningitis outbreak is not your typical pharmaceutical case. Most drug injury cases involve some defect in the drug or in the warning or in the design of the drug. This case is differen...
See Full GuideIn 2002, the FDA gave limited permission to a company called Medtronic to market its new medical device called the Infuse Bone Implant System. This permission was limited to a frontal surgical approach...
See Full GuideAd
Transform legal challenges into solutions.
Connect now to review your situation.
